ArticleNanoscale research letters2010
Nanodiamonds as Carriers for Address Delivery of Biologically Active Substances.
Article in Nanoscale research letters, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 110 citations in OpenAlex.
- Nanoscale Diamond-Based Formulation as an Immunomodulator and Potential Therapeutic for Lymphoma.Frontiers in pharmacology · 2022Article
- Study on Structure, Thermal Behavior and Viscoelastic Properties of Nanodiamond-Reinforced Poly (vinyl alcohol) Nanocomposites.Polymers · 2021Article
- Nanodiamonds with powerful ability for drug delivery and biomedical applications: Recent updates on in vivo study and patents.Journal of pharmaceutical analysis · 2020Review
- Treating Polymicrobial Infections in Chronic Diabetic Wounds.Clinical microbiology reviews · 2019Review
- Characterization of Nanodiamond-based anti-HIV drug Delivery to the Brain.Scientific reports · 2018Article
- Detection of nanodiamonds in biological samples by EPR spectrometry.Doklady. Biochemistry and biophysics · 2017Article
- Multifunctional nanodiamonds in regenerative medicine: Recent advances and future directions.Journal of controlled release : official journal of the Controlled Release Society · 2017Review
- Vascular thrombus imaging in vivo via near-infrared fluorescent nanodiamond particles bioengineered with the disintegrin bitistatin (Part II).International journal of nanomedicine · 2017Article
- Nanodiamond-Gadolinium(III) Aggregates for Tracking Cancer Growth In Vivo at High Field.Nano letters · 2016Article
- Role of Nanodiamonds in Drug Delivery and Stem Cell Therapy.Iranian journal of biotechnology · 2016Review
- Solid-phase synthesis, characterization, and cellular activities of collagen-model nanodiamond-peptide conjugates.Biopolymers · 2015Article
- Binding the immunoglobulins of human serum by nanodiamonds.Doklady. Biochemistry and biophysics · 2014Article
- Spontaneous formation of graphene-like stripes on high-index diamond C(331) surface.Nanoscale research letters · 2012Article
- The biocompatibility of nanodiamonds and their application in drug delivery systems.Theranostics · 2012Article
- The properties and applications of nanodiamonds.Nature nanotechnology · 2011Review
- Luminescent nanodiamonds for biomedical applications.Biophysical reviews · 2011Review
- Modified nanodiamonds obtained by detonation synthesis in constructing biochemical indication systems (As exemplified by the glucose determination system).Doklady. Biochemistry and biophysicsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surface of detonation nanodiamonds was functionalized for the covalent attachment of immunoglobulin, and simultaneously bovine serum albumin and Rabbit Anti-Mouse Antibody. The nanodiamond-IgG(I125) and RAM-nanodiamond-BSA(I125) complexes are stable in blood serum and the immobilized proteins retain their biological activity. It was shown that the RAM-nanodiamond-BSA(I125) complex is able to bind to the target antigen immobilized on the Sepharose 6B matrix through antibody-antigen interaction. The idea can be extended to use nanodiamonds as carriers for delivery of bioactive substances (i.e., drugs) to various targets in vivo.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.